» Articles » PMID: 19713265

Sugammadex Provides Faster Reversal of Vecuronium-induced Neuromuscular Blockade Compared with Neostigmine: a Multicenter, Randomized, Controlled Trial

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2009 Aug 29
PMID 19713265
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sugammadex, a specifically designed gamma-cyclodextrin, is a selective relaxant binding drug that rapidly reverses rocuronium-induced and, to a lesser extent, vecuronium-induced neuromuscular blockade. In this study, we compared the efficacy of sugammadex and neostigmine for the reversal of vecuronium-induced neuromuscular blockade in patients scheduled for elective surgery.

Methods: Patients aged > or = 18 yr, ASA Class I-III, and scheduled for a surgical procedure under sevoflurane/opioid anesthesia received an intubating dose of vecuronium (0.1 mg/kg) and maintenance doses of 0.02-0.03 mg/kg at reappearance of the second twitch (T(2)) of train-of-four (TOF) if required. Neuromuscular blockade was monitored using acceleromyography (TOF-Watch SX, Schering-Plough Ireland, Dublin, Ireland). At end of surgery, at reappearance of T(2) after the last dose of vecuronium, patients were randomized to receive either sugammadex (2 mg/kg) or neostigmine (50 microg/kg) plus glycopyrrolate (10 microg/kg) i.v.. The primary efficacy end-point was time from start of administration of sugammadex or neostigmine to recovery of TOF ratio to 0.9.

Results: The geometric mean time to recovery of the TOF ratio to 0.9 was significantly faster with sugammadex compared with neostigmine (2.7 min [95% confidence interval {CI}]: 2.2-3.3) versus 17.9 min [95% CI: 13.1-24.3], respectively; P < 0.0001). The mean recovery times to a TOF ratio of 0.8 and 0.7 were also significantly shorter with sugammadex. No serious adverse events or unexpected side effects were reported with either drug.

Conclusion: Sugammadex provided significantly faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine.

Citing Articles

State-of-the-art anesthesia practices: a comprehensive review on optimizing patient safety and recovery.

Fu G, Xu L, Chen H, Lin J BMC Surg. 2025; 25(1):32.

PMID: 39833810 PMC: 11749226. DOI: 10.1186/s12893-025-02763-6.


Sugammadex vs Neostigmine, a Comparison in Reversing Neuromuscular Blockade: A Narrative Review.

Maqusood S, Bele A, Verma N, Dash S, Bawiskar D Cureus. 2024; 16(7):e65656.

PMID: 39205735 PMC: 11352768. DOI: 10.7759/cureus.65656.


Effects of the attachment method of the stimulating electrodes Nihon-Kohden NM-345Y™ and changes in forearm position on stimulus current values during calibration in electromyography-based neuromuscular monitoring: a single-center experimental....

Makino M, Kaneko S, Sato S, Kawazoe Y, Ichinomiya T, Murata H J Anesth. 2023; 37(6):888-895.

PMID: 37653275 DOI: 10.1007/s00540-023-03250-z.


Safety and Efficacy of 4 mg·kg⁻¹ Sugammadex for Simultaneous Pancreas-Kidney Transplantation Recipients: A Prospective Randomized Trial.

Tang J, He R, Zhang L, Xu S Ann Transplant. 2023; 28:e940211.

PMID: 37218125 PMC: 10224634. DOI: 10.12659/AOT.940211.


Comparison of neostigmine and sugammadex for hemodynamic parameters in neurointerventional anesthesia.

Tsai Y, Chen C, Wong H, Chou A Front Neurol. 2023; 14:1045847.

PMID: 37139057 PMC: 10150384. DOI: 10.3389/fneur.2023.1045847.